Pharmacological Considerations during Percutaneous Treatment of Heart Failure

Area of Science:

• Cardiology
• Interventional Cardiology
• Heart Failure Management

Background:

• Heart Failure (HF) presents a significant global health burden with high morbidity and mortality.
• While treatments have improved prognosis, long-term outcomes remain challenging.
• Interventional cardiology provides percutaneous treatments for acute and chronic HF.

Purpose of the Study:

• To review the role of percutaneous interventions in managing Heart Failure patients.
• To focus on the key features, clinical effectiveness, and safety of these procedures.
• To identify evidence gaps and future research needs in this field.

Main Methods:

• Comprehensive literature review of percutaneous interventions in HF.
• Analysis of clinical effectiveness and safety data.
• Identification of current evidence limitations.

Main Results:

• Percutaneous interventions are increasingly utilized in HF management.
• These treatments offer diverse options for both acute and chronic HF.
• Significant gaps in evidence exist regarding optimal patient selection and long-term benefits.

Conclusions:

• Percutaneous interventions play a crucial role in modern HF care.
• High-quality randomized trials and international registries are essential.
• Further research will clarify the specific patient groups and scenarios benefiting most from these devices.